Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Atzinger

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
The Lancet. Rheumatology|January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot studyChristina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Nature Immunology|February 24, 2024
CD200<sup>+</sup> fibroblasts form a pro-resolving mesenchymal network in arthritisSimon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Medicine|April 17, 2025
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cellsFabian Müller, Andreas Wirsching, Melanie Hagen, et al.
Annals of the Rheumatic Diseases|July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imagingChristian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
The Lancet. Rheumatology|January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot studyChristina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Nature Immunology|February 24, 2024
CD200<sup>+</sup> fibroblasts form a pro-resolving mesenchymal network in arthritisSimon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Pageof 3